In this interview, Raj Puri, chief commercial officer at Argonaut Manufacturing, discusses the complex challenges and shifting strategies within the U.S. pharmaceutical supply chain. Argonaut, a contract manufacturing organization based in Carlsbad, California, operates specialized divisions for life science diagnostics and aseptic drug product filling. Puri identifies the unexpected 2025 White House tariffs on equipment and consumables as a significant disruption for mid-sized companies attempting to expand domestic infrastructure.
Puri highlights the financial strain these policies impose, noting that Argonaut itself was hit with a seven-figure…